424 related articles for article (PubMed ID: 11158333)
1. Distinct functions of the two protein tyrosine phosphatase domains of LAR (leukocyte common antigen-related) on tyrosine dephosphorylation of insulin receptor.
Tsujikawa K; Kawakami N; Uchino Y; Ichijo T; Furukawa T; Saito H; Yamamoto H
Mol Endocrinol; 2001 Feb; 15(2):271-80. PubMed ID: 11158333
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Lck and Fyn tyrosine kinase activities by transmembrane protein tyrosine phosphatase leukocyte common antigen-related molecule.
Tsujikawa K; Ichijo T; Moriyama K; Tadotsu N; Sakamoto K; Sakane N; Fukada S; Furukawa T; Saito H; Yamamoto H
Mol Cancer Res; 2002 Dec; 1(2):155-63. PubMed ID: 12496362
[TBL] [Abstract][Full Text] [Related]
3. Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR.
Zhang WR; Li PM; Oswald MA; Goldstein BJ
Mol Endocrinol; 1996 May; 10(5):575-84. PubMed ID: 8732688
[TBL] [Abstract][Full Text] [Related]
4. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
Ahmad F; Goldstein BJ
J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and expression of a unique receptor-like protein-tyrosine-phosphatase in the leucocyte-common-antigen-related phosphate family.
Zhang WR; Hashimoto N; Ahmad F; Ding W; Goldstein BJ
Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):39-47. PubMed ID: 8068021
[TBL] [Abstract][Full Text] [Related]
6. Insulin receptor protein-tyrosine phosphatases. Leukocyte common antigen-related phosphatase rapidly deactivates the insulin receptor kinase by preferential dephosphorylation of the receptor regulatory domain.
Hashimoto N; Feener EP; Zhang WR; Goldstein BJ
J Biol Chem; 1992 Jul; 267(20):13811-4. PubMed ID: 1321126
[TBL] [Abstract][Full Text] [Related]
7. Specific interaction of the CD45 protein-tyrosine phosphatase with tyrosine-phosphorylated CD3 zeta chain.
Furukawa T; Itoh M; Krueger NX; Streuli M; Saito H
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10928-32. PubMed ID: 7526385
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor and epidermal growth factor receptor dephosphorylation by three major rat liver protein-tyrosine phosphatases expressed in a recombinant bacterial system.
Hashimoto N; Zhang WR; Goldstein BJ
Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):569-76. PubMed ID: 1599438
[TBL] [Abstract][Full Text] [Related]
9. The protein tyrosine phosphatase LAR has a major impact on insulin receptor dephosphorylation.
Mooney RA; Kulas DT; Bleyle LA; Novak JS
Biochem Biophys Res Commun; 1997 Jun; 235(3):709-12. PubMed ID: 9207225
[TBL] [Abstract][Full Text] [Related]
10. Knock-down of LAR protein tyrosine phosphatase induces insulin resistance.
Mander A; Hodgkinson CP; Sale GJ
FEBS Lett; 2005 Jun; 579(14):3024-8. PubMed ID: 15896785
[TBL] [Abstract][Full Text] [Related]
11. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects.
Ahmad F; Considine RV; Goldstein BJ
J Clin Invest; 1995 Jun; 95(6):2806-12. PubMed ID: 7769120
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase regulation in fibroblasts from patients with an insulin receptor gene mutation.
Seki N; Yagi S; Suzuki Y; Shimada F; Taira M; Makino H; Amano K; Yagui K; Saito Y; Hashimoto N
Horm Metab Res; 2008 Dec; 40(12):833-7. PubMed ID: 18925540
[TBL] [Abstract][Full Text] [Related]
13. NMR analysis of regioselectivity in dephosphorylation of a triphosphotyrosyl dodecapeptide autophosphorylation site of the insulin receptor by a catalytic fragment of LAR phosphotyrosine phosphatase.
Lee JP; Cho H; Bannwarth W; Kitas EA; Walsh CT
Protein Sci; 1992 Oct; 1(10):1353-62. PubMed ID: 1303753
[TBL] [Abstract][Full Text] [Related]
14. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.
Ahmad F; Azevedo JL; Cortright R; Dohm GL; Goldstein BJ
J Clin Invest; 1997 Jul; 100(2):449-58. PubMed ID: 9218523
[TBL] [Abstract][Full Text] [Related]
15. Cloning, bacterial expression, purification, and characterization of the cytoplasmic domain of rat LAR, a receptor-like protein tyrosine phosphatase.
Pot DA; Woodford TA; Remboutsika E; Haun RS; Dixon JE
J Biol Chem; 1991 Oct; 266(29):19688-96. PubMed ID: 1918076
[TBL] [Abstract][Full Text] [Related]
16. Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells.
Li PM; Zhang WR; Goldstein BJ
Cell Signal; 1996 Nov; 8(7):467-73. PubMed ID: 9023010
[TBL] [Abstract][Full Text] [Related]
17. LAR-PTPase cDNA transfection suppression of tumor growth of neu oncogene-transformed human breast carcinoma cells.
Zhai Y; Wirth J; Kang S; Welsch CW; Esselman WJ
Mol Carcinog; 1995 Oct; 14(2):103-10. PubMed ID: 7576097
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of the catalytic domains of the human receptor-linked protein tyrosine phosphatases HPTP beta, leukocyte common antigen (LCA), and leukocyte common antigen-related molecule (LAR).
Itoh M; Streuli M; Krueger NX; Saito H
J Biol Chem; 1992 Jun; 267(17):12356-63. PubMed ID: 1318316
[TBL] [Abstract][Full Text] [Related]
19. The phosphatase domains of LAR, CD45, and PTP1B: structural correlations with peptide-based inhibitors.
Glover NR; Tracey AS
Biochem Cell Biol; 2000; 78(1):39-50. PubMed ID: 10735562
[TBL] [Abstract][Full Text] [Related]
20. Dephosphorylation of autophosphorylated insulin and epidermal-growth-factor receptors by two major subtypes of protein-tyrosine-phosphatase from human placenta.
Tappia PS; Sharma RP; Sale GJ
Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):69-74. PubMed ID: 1715686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
